E
ELEVAI LABS, INC. COMMON STOCK
NASDAQ: ELAB (PMGC Holdings Inc.)
Last update: 1 hour ago5.09
0.06 (1.19%)
| Previous Close | 5.03 |
| Volume | 77,285 |
| Price / Sales | 0.310 |
| Price / Book | 0.280 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -9.44 |
| Quarterly Revenue Growth (YOY) | -4.90% |
| Total Debt/Equity (MRQ) | 1.21% |
| Current Ratio (MRQ) | 8.97 |
| Operating Cash Flow (TTM) | -4.51 M |
| Levered Free Cash Flow (TTM) | -2.28 M |
| Return on Assets (TTM) | -36.92% |
| Return on Equity (TTM) | -95.21% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | PMGC Holdings Inc. | - | - |
AIStockmoo Score
-0.8
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.83 |
|
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 0.34% |
| % Held by Institutions | 2.99% |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |